Posted on October 4th, 2011 by
Plasma levels of sphingolipid compounds can predict progression of Alzheimer's disease, a small, early, observational study showed.Higher ratios of sphingomyelins to ceramide and of dihydrosphingomyelin to dihydroceramides predicted significantly slower clinical progression, Michelle M. Mielke, PhD, of Johns Hopkins University, and colleagues found. Mielke is now at Mayo Clinic in Rochester, Minn.
MedPage Today, Crystal Phend, 10/4/11
You must be logged-in to the site to post a comment.